Company attributes
Industry
B2X
CEO
Founder
AngelList URL
Pitchbook URL
Legal Name
Dynavax Technologies Corporation
Number of Employees (Ranges)
201 – 5000
Email Address
contact@dynavax.com0
Phone Number
+151084851000
Number of Employees
3110
Full Address
2100 Powell Street, Suite 900 Emeryville, CA 946080
CIK Number
Place of Incorporation
Investors
DUNS Number
9641738010
IRS Number
330,728,3740
Founded Date
1996
Fax Number
+1.510.848.13270
Total Funding Amount (USD)
20,067,480
Latest Funding Round Date
January 7, 2010
Business Model
Commerce
Licensing
Stock Symbol
DVAX0
Exchange
Board of Directors
Key People
NAICS Code
325,4120
CAGE Code
4BYD40
Patents Assigned (Count)
53
COO
Wellfound ID
Country
Other attributes
Company Operating Status
Active
SIC Code
2,8340
Ticker Symbol
DVAX
Wikidata ID
Dynavax Technologies is a California-based company in the biotechnology industry with a focus on developing novel vaccines. Its first commercial product was a Hepatitis B vaccine called HEPLISAV-B.It develops its medical solutions using Toll-like Receptor (TLR) technology.
COVID-19
The company entered into a partnership with Clover Biopharmaceuticals, a Chinese biotechnology company, to develop a vaccine candidate for COVID-19. The company's roll in the partnership includes technical expertise as well as CpG 1018, an adjuvant that is used in creating vaccines such as the company's own HEPLISAV-B.
Dynavax Technologies also partnered with Sinovac to combine its adjuvant CpG 1018 with Sinovac's chemically inactivated vaccine candidate for COVID-19.
Timeline
No Timeline data yet.
